Biological properties of dendritic cells: Implications to their use in the treatment of cancer

Molecular Medicine Today

Volumn 3, Issue 6, 1997, Pages 254-260

  Van Schooten, W C A ^a   Strang, G ^a   Palathumpat, V ^a  

^a Activated Cell Therapy   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADOPTIVE TRANSFER; B CELL LYMPHOMA; CANCER; CANCER PREVENTION; CLINICAL TRIAL; DENDRITIC CELL; EFFECTOR CELL; GENE THERAPY; HUMAN; MELANOMA; MULTIPLE MYELOMA; NONHUMAN; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0031430657     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(97)01047-2     Document Type: Review

References (44)

1. Steinman R.M. Cohn Z.A. Identification of a novel cell type in peripheral lymphoid organs in mice. I. Morphology, quantitation, tissue distribution J. Exp. Med. 137 1973 1142 1158
2. Romani N. Cultured human Langerhans cells resemble lymphoid dendritic cells in phenotype and function J. Invest. Dermatol. 93 1989 600 609
3. Greenberg P.D. Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells Adv. Immunol. 49 1991 281 355
4. + T cells J. Immunol. 154 1995 5071 5079
5. Gajewski T.F. Renauld J-C. Van Pel A. Boon T. Costimulation with B7-1, IL-6, and IL-12 is sufficient for primary generation of murine antitumor cytolytic T lymphocytes in vitro J. Immunol. 154 1995 5637 5648
6. Steinman R.M. The dendritic cell system and its role in immunogenicity Annu. Rev. Immunol. 9 1991 271 296
7. Matsumo K. Ezaki T. Kudo S. Uehara Y. A life stage of particle-laden rat dendritic cells in vivo : their terminal division, active phagocytosis, and translocation from the liver to the draining lymph node J. Exp. Med. 183 1996 1865 1878
8. Inaba K. The tissue distribution of the B7-2 costimulator in mice: abundant expression on dendritic cells in situ and during maturation in vitro J. Exp. Med. 180 1994 1849 1860
9. Freudenthal P.S. Steinman R.M. The distinct surface of human blood dendritic cells, as observed after an improved isolation method Proc. Natl. Acad. Sci. U. S. A. 87 1990 7698 7702
10. Thomas R. Lipsky P.E. Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells J. Immunol. 153 1994 4016 4028
11. Galy A. Travis M. Cen D. Chen B. Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset Immunity 3 1995 459 473
12. Inaba K. Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow Proc. Natl. Acad. Sci. U. S. A. 90 1993 3039 3042
13. + peripheral blood monocytes J. Immunol. 157 1996 3850 3859
14. Rossi G. Development of a Langerhans cell phenotype from peripheral blood monocytes Immunol. Lett. 31 1992 189 198
15. Kasinrerk W. CD1 molecule expression on human monocytes induced by granulocyte-macrophage colony-stimulating factor J. Immunol. 150 1993 579 584
16. Ruppert J. Friedrichs D. Xu H. Peters J.H. IL-4 decreases the expression of the monocyte differentiation marker CD14, paralleled by an increasing accessory potency Immunobiology 182 1991 449 464
17. Jaffe R. Review of human dendritic cells Ped. Path. 13 1993 821 837
18. Kabel P.J. Accessory cells with a morphology and marker pattern of dendritic cells can be obtained from elutriator-purified blood monocyte fractions. An enhancing effect of metrizamide in this differentiation Immunobiology 179 1989 395 411
19. + CTLs from naive precursors J. Immunol. 153 1994 996 1003
20. Sallusto F. Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α J. Exp. Med. 179 1994 1109 1118
21. Egner W. Hart D.N.J. The phenotype of freshly isolated and cultured human bone marrow allostimulatory cells: possible heterogeneity in bone marrow dendritic cell populations Immunology 85 1995 611 620
22. − T lymphocytes to a microbial antigen Nature 360 1992 593 597
23. Takahashi K. Induction of interdigitating reticulum cell-like differentiation in human monocytic leukemia cells by conditioned medium from IL-2-stimulated T cells Virchows Arch. B Cell Pathol. 62 1992 105 113
24. Kaiserling E. Horny H.P. Dermal Langerhans cell tumor in chronic myelomonocytic leukemia Ultrastruct. Path. 12 1988 209 219
25. Paglia P. Chiodoni C. Rodolfo M. Colombo M.P. Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo J. Exp. Med. 183 1996 317 322
26. Boczkowski D. Nair S.K. Snyder D. Gilboa E. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo J. Exp. Med. 184 1996 465 472
27. Rouse R.J.D. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins J. Virol. 68 1994 5685 5689
28. Nair S. Soluble proteins delivered to dendritic cells via pH-sensitive liposomes induce primary cytotoxic T lymphocyte responses in vitro J. Exp. Med. 175 1992 609 612
29. Zitvogel L. Therapy of murine tumors with tumor peptide-pulsed dendritic cells: Dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines J. Exp. Med. 183 1996 87 97
30. Mayordomo J.I. Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity Nat. Med. 1 1995 1297 1302
31. Ossevoort M.A. Dendritic cells as carriers for a cytotoxic T-lymphocyte epitope-based peptide vaccine in protection against a human papillomavirus type 16-induced tumor J. Immunother. 18 1995 86 94
32. Flamand V. Murine dendritic cells pulsed in vitro with tumor antigen induce tumor resistance in vivo Eur. J. Immunol. 24 1994 605 610
33. Ridge J.P. Fuchs E.J. Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells Science 271 1996 1723 1726
34. Hsu F.J. Vaccination of patients with B cell lymphoma using autologous antigen pulsed dendritic cells Nat. Med. 2 1996 52 58
35. Takamizawa M. Cellular and molecular basis of human γδ T cell activation: role of accessory molecules in alloactivation J. Clin. Invest. 95 1995 296 303
36. (Abstract) Reichardt V. Idiotypic vaccination using dendritic cells for multiple myeloma patients after autologous peripheral blood stem cell transplantation Blood 88 1996 481
37. Mukherji B. Induction of antigen-specific cytolytic T cells in situ in human melanoma by immunization with synthetic peptide-pulsed autologous antigen presenting cells Proc. Natl. Acad. Sci. U. S. A. 92 1995 8078 8082
38. Dupuis M. Allogeneic dendritic cell induction of HIV-specific cytotoxic T lymphocyte responses from T cells of HIV type 1-infected and uninfected individuals AIDS Res. Hum. Retroviruses 13 1997 33 39
39. McLellan A.D. Starling G.C. Hart D.N.J. Isolation of human blood dendritic cells by discontinuous Nycodenz gradient centrifugation J. Immunol. Methods 184 1995 81 89
40. + cytotoxic T-lymphocytes for adoptive immunotherapy Biotech. Bioeng. 50 1996 529 540
41. Thomas R. Davis L.S. Lipsky P.E. Isolation and characterization of human peripheral blood dendritic cells J. Immunol. 150 1993 821 834
42. Markowicz S. Engleman E.G. Granulocyte-macrophage colony-stimulating factor promotes differentiation and survival of human peripheral blood dendritic cells in vitro J. Clin. Invest. 85 1990 955 961
43. Santiago-Schwarz F. Belilos E. Diamond B. Carsons S.E. TNF in combination with GM-CSF enhances the differentiation of neonatal cord blood stem cells into dendritic cells and macrophages J. Leuk. Biol. 52 1992 274 281
44. Ardavin C. Wu L. Li C.L. Shortman K. Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population Nature 362 1993 761 763